Gallbladder cancer laboratory tests: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
==Laboratory tests== | ==Laboratory tests== | ||
Transabdominal ultrasound, CT scan, endoscopic ultrasound, MRI, MR cholangio-pancreatography (MRCP), [[CEA]], [[CA 19-9]] and [[liver function tests]] can be used for diagnosis. A biopsy is the only certain way to tell whether the tumorous growth is malignant or not | Transabdominal [[ultrasound]], [[CT]] scan, endoscopic [[ultrasound]], [[MRI]], MR cholangio-pancreatography (MRCP), [[CEA]], [[CA 19-9]] and [[liver function tests]] can be used for diagnosis. A biopsy is the only certain way to tell whether the tumorous growth is malignant or not | ||
==References== | ==References== | ||
Revision as of 18:19, 25 August 2015
|
Gallbladder cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gallbladder cancer laboratory tests On the Web |
|
American Roentgen Ray Society Images of Gallbladder cancer laboratory tests |
|
Risk calculators and risk factors for Gallbladder cancer laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Laboratory findings consistent with the diagnosis of gallbladder cancer include abnormal liver function tests and elevated CA 19-9 and CEA levels.
Laboratory tests
Transabdominal ultrasound, CT scan, endoscopic ultrasound, MRI, MR cholangio-pancreatography (MRCP), CEA, CA 19-9 and liver function tests can be used for diagnosis. A biopsy is the only certain way to tell whether the tumorous growth is malignant or not
References